iGMDRD71
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|
Sparfosic acid | CHEMBL504802 | 39981 | DB03459 | Alone | DNC000976 | Small Molecule |
Drug Class:
AcetatesAcids, AcyclicAmino AcidsAmino Acids, AcidicAmino Acids, DicarboxylicAmino Acids, Peptides, and ProteinsAnti-Infective AgentsAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntiviral AgentsCarboxylic AcidsEnzyme InhibitorsExcitatory Amino AcidsFatty AcidsFatty Acids, VolatileLipidsNoxaeOrganophosphonatesOrganophosphorus CompoundsToxic ActionsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
3696 | ITGB8 | 2 |
64901 | RANBP17 | 3 |
8999 | CDKL2 | 3 |
10641 | NPRL2 | 1 |
6581 | SLC22A3 | 3 |
1588 | CYP19A1 | 3 |
347365 | ITIH6 | 2 |
51347 | TAOK3 | 3 |
2100 | ESR2 | 3 |
701 | BUB1B | 3 |
7444 | VRK2 | 3 |
2241 | FER | 3 |
341676 | NEK5 | 2 |
2984 | GUCY2C | 3 |
2033 | EP300 | 3 |
8030 | CCDC6 | 3 |
4595 | MUTYH | 2 |
23522 | KAT6B | 3 |
22861 | NLRP1 | 2 |
342977 | NANOS3 | 2 |
3621 | ING1 | 3 |
23012 | STK38L | 3 |
32 | ACACB | 2 |
4752 | NEK3 | 3 |
2521 | FUS | 3 |
5924 | RASGRF2 | 3 |
23152 | CIC | 3 |
6092 | ROBO2 | 3 |
9639 | ARHGEF10 | 2 |
6197 | RPS6KA3 | 2 |
652 | BMP4 | 2 |
7175 | TPR | 3 |
54106 | TLR9 | 3 |
6654 | SOS1 | 3 |
51366 | UBR5 | 3 |
9972 | NUP153 | 3 |
4145 | MATK | 3 |
841 | CASP8 | 2 |
5156 | PDGFRA | 3 |
27330 | RPS6KA6 | 3 |
89795 | NAV3 | 1 |
5205 | ATP8B1 | 3 |
23118 | TAB2 | 3 |
1950 | EGF | 2 |
91807 | MYLK3 | 3 |
2869 | GRK5 | 3 |
81608 | FIP1L1 | 3 |
317 | APAF1 | 3 |
9021 | SOCS3 | 2 |
10111 | RAD50 | 3 |
100124696 | TEC | 3 |
57118 | CAMK1D | 3 |
4221 | MEN1 | 3 |
7112 | TMPO | 3 |
444 | ASPH | 3 |
2903 | GRIN2A | 3 |
4299 | AFF1 | 3 |
374 | AREG | 3 |
3092 | HIP1 | 3 |
1499 | CTNNB1 | 3 |
Gene in drug-gene network: Network Plot
Models in Sparfosic acid